✦ LIBER ✦

A double blind placebo-controlled randomized trial of fluvastatin after successful percutaneous intervention in patients with coronary heart disease: the Lescol Intervention Prevention Study (LIPS)

✍ Scribed by Patrick W. Serruvs

Book ID: 119543729
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 143 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80175-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracoronary nitroprusside for the prev

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial

✍ Guy Amit; Carlos Cafri; Sergei Yaroslavtsev; Shmuel Fuchs; Ora Paltiel; Akram Ab 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A multi-center randomized double-blind p

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

✍ Qing-hua Shang; Hao Xu; Xiao-yan Lu; Chuan Wen; Da-zhuo Shi; Ke-ji Chen 📂 Article 📅 2011 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 514 KB

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Double-Blind Parallel Placebo-Controlled

Double-Blind Parallel Placebo-Controlled Study to Evaluate the Effect of Molsidomine on the Endothelial Dysfunction in Patients with Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention: the MEDCOR Trial

✍ Barbato, Emanuele; Herman, Arnold; Benit, Edouard; Janssens, Luc; Lalmand, Jacqu 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 189 KB

Letter of comment on “Intracoronary nitr

Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J 2006;152:887.e9-14)

✍ Tom Vydt; Pierfrancesco Agostoni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Abciximab and angiographic restenosis af

Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT—A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel

✍ Helmut Schühlen; Adnan Kastrati; Julinda Mehilli; Jörg Hausleiter; Josef Dirschi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB